Computerized measurements of inhalation ability with a dry powder inhaler in patients with severe COPD

E. Björk (Stockholm, Sweden), P. Thind (Stockholm, Sweden), M. Qvarfordt (Uppsala, Sweden), M. Svartengren (Uppsala, Sweden), M. Anderson (Stockholm, Sweden)

Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Session: Inhaler devices in COPD: technical advances, adherence studies and more
Session type: E-poster session
Number: 644
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Björk (Stockholm, Sweden), P. Thind (Stockholm, Sweden), M. Qvarfordt (Uppsala, Sweden), M. Svartengren (Uppsala, Sweden), M. Anderson (Stockholm, Sweden). Computerized measurements of inhalation ability with a dry powder inhaler in patients with severe COPD. 644

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Carbon footprint of severe asthma exacerbation management relative to Breezhaler dry powder inhaler
Source: Virtual Congress 2021 – Environment and respiratory health
Year: 2021



Improving inhalation parameters through dry powder inhalers (DPIs) after an acute asthma exacerbation
Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma
Year: 2012


The investigation of inhalation continuous duration for dry powder inhalers in asthmatic patients
Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs
Year: 2012


Dose delivery characteristics of two dry powder inhalers in COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 291s
Year: 2004

Handling and patient preference of dry powder inhalers for asthma and COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 210s
Year: 2006

Oral manifestations in asthmatic patients using metered dose inhaler and dry powder inhaler
Source: International Congress 2019 – Innovations in primary care assessment and management
Year: 2019

Inhaler treatment options in COPD
Source: Eur Respir Rev 2005; 14: 102-108
Year: 2005



Use of dry powder inhalers in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 286s
Year: 2005

Inhaler choice in primary practice
Source: Eur Respir Rev 2005; 14: 117-122
Year: 2005



Efficacy and safety of salbutamol delivered via a novel multidose dry powder inhaler in comparison with two conventional dry powder inhalers and a pMDI in asthmatic subjects
Source: Eur Respir J 2001; 18: Suppl. 33, 50s
Year: 2001

Inspiratory profiles and resistance of two dry powder inhalers in COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 291s
Year: 2004

Effect of switching from salmeterol/fluticasone dry powder inhaler to formoterol/fluticasone pressurized metered-dose inhaler in elderly asthma patients
Source: International Congress 2016 – Asthma management
Year: 2016


Comparison of two dry powder inhalers containing budesonide in the treatment of asthma in children
Source: Eur Respir J 2002; 20: Suppl. 38, 500s
Year: 2002

Broncho dilator response to salbutamol delivered by metered dose inhaler with spacer versus dry powder inhaler in acute asthma in children
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016

Peak inspiratory flow rates through placebo dry powder inhaler device in various asthma and COPD patients
Source: Annual Congress 2012 - Asthma management
Year: 2012


Applicability of dry powder inhalers in children with CF
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016


Inspiratory profiles and consistency of behaviour regarding dose delivery characteristics of two dry powder inhalers in COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 13s
Year: 2004

A novel NEXT DPI® dry powder inhaler and its use in asthmatic and COPD population
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I
Year: 2011

Comparison of a formoterol multiple dose dry powder inhaler (MDPI) with a formoterol single dose dry powder inhaler (SDPI) in patients with moderate to severe asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 260s
Year: 2004

Assessment of usability of a novel multi-dose dry powder inhaler in healthy volunteers and mild asthmatics
Source: Eur Respir J 2007; 30: Suppl. 51, 70s
Year: 2007